Projects per year
Personal profile
Education/Academic qualification
Hematology/Oncology, Clinical Fellowship, LAC-Olive View/UCLA Medical Center
Jul 1 2004 → Jun 30 2007
Award Date: Jun 30 2007
Internal Medicine, Residency, LAC-Harbor-UCLA Medical Center
Jun 1 2002 → Jun 30 2004
Award Date: Jun 30 2004
Internal Medicine, Internship, LAC-Harbor-UCLA Medical Center
Jun 1 2001 → Jun 30 2002
Award Date: Jun 30 2002
MD, University of California at Los Angeles School of Medicine
Jul 1 1997 → Jun 30 2001
Award Date: Jun 30 2001
Research Area Keywords
- Cancer
- Digestive Disorders
Fingerprint
Dive into the research topics where Monisha Singh is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy
Niravath, P. A. (PI), Antosh, D. (Key Personnel), Chaaya, G. (Key Personnel), Chang, J. C. (Key Personnel), High, R. A. (Key Personnel), Mai, H. P. (Key Personnel), Singh, M. (Key Personnel), Sun, K. (Key Personnel) & Zaid, T. (Key Personnel)
5/17/24 → …
Project: Clinical Trial
-
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients with Hepatocellular Carcinoma Beyond Milan Criteria: A Feasibility Study
Abdelrahim, M. (PI), Connor, A. A. (Key Personnel), Ghobrial, R. M. (Key Personnel), Gibbs, J. M. (Key Personnel), Graviss, E. A. (Key Personnel), Gupta, N. (Key Personnel), Kodali, S. (Key Personnel), Mobley, C. M. (Key Personnel), Moore, L. W. (Key Personnel), Rizk, E. (Key Personnel), Saharia, A. (Key Personnel), Singh, M. (Key Personnel) & Victor, III, D. W. (Key Personnel)
1/18/23 → …
Project: Clinical Trial
-
A Phase 3, Randomized, Open-label Study to Evaluate Perioperative Enfortumab Vedotin Plus Pembrolizumab (MK-3475) Versus Neoadjuvant Gemcitabine and Cisplatin in Cisplatin-eligible Participants With Muscle-invasive Bladder Cancer (KEYNOTE-B15 / EV-304)
Satkunasivam, R. (PI), Singh, M. (Key Personnel) & Zhang, J. (Key Personnel)
9/15/21 → …
Project: Clinical Trial
-
An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-ResistantOvarian Cancer
Kamat, A. A. (PI), Alaniz, A. (CoI), Darcourt, J. (CoI), Singh, M. (CoI), Suri, A. (CoI) & Zaid, T. (CoI)
3/15/21 → 3/14/46
Project: Non Profit
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C. (PI), Bernicker, E. H. (Key Personnel), Darcourt, J. (Key Personnel), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
4/9/20 → …
Project: Clinical Trial
Research output
- 7 Article
-
1233 Impact of infections occurring in patients receiving immune checkpoint inhibitors for renal cell carcinoma (RCC)
Wiechmann, C., Gee, K., Burns, E. A., Xu, J., Zhang, Y., Crenshaw, A., Esmail, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Efstathiou, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1360-A1360Research output: Contribution to journal › Article › peer-review
-
1234 Impact of infections in patients receiving immune checkpoint inhibitor therapies for non-small cell lung cancer (NSCLC)
Gee, K., Wiechmann, C., Burns, E. A., Xu, J., Zhang, Y., Esmail, A., Crenshaw, A., Kieser, R. B., Umoru, G., Muhsen, I., Sun, K., Gong, Z., Shah, S., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., 2023, In: Journal for immunotherapy of cancer. 11, Suppl 1, p. A1361-A1361Research output: Contribution to journal › Article › peer-review
-
480 Impact of infections in patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving pembrolizumab-based therapies
Burns, E. A., Xu, J., Kieser, R., Muhsen, I., Shah, S., Umoru, G., Mylavarapu, C., Zhang, Y., Crenshaw, A., Sun, K., Esmail, A., Guerrero, C., Gong, Z., Gee, K., Heyne, K., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., Nov 1 2022, In: J Immunother Cancer. 10, Suppl 2, p. A501Research output: Contribution to journal › Article › peer-review
-
Impact of Infections in Patients Receiving Pembrolizumab-Based Therapies for Non-Small Cell Lung Cancer
Burns, E. A., Gee, K., Kieser, R. B., Xu, J., Zhang, Y., Crenshaw, A., Muhsen, I. N., Mylavarapu, C., Esmail, A., Shah, S., Umoru, G., Sun, K., Guerrero, C., Gong, Z., Heyne, K., Singh, M., Zhang, J., Bernicker, E. H. & Abdelrahim, M., Dec 23 2022, In: Cancers. 15, 1, 81.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Infections and their impact on patients on pembrolizumab-based therapies for head and neck cancer. Journal of Clinical Oncology
Zhang, Y., Xu, J., Muhsen, I., Burns, E. A., Shah, S. M., Umoru, G., Mylavarapu, C., Sun, K., Crenshaw, A., Esmail, A., Kieser, R. B., Guerrero, C., Gong, Z., Gee, K., Heyne, K., Singh, M., Zhang, J. & Abdelrahim, M., 2022, In: Journal of Clinical Oncology. 40, 16_suppl, p. 6035 1 p.Research output: Contribution to journal › Article › peer-review